Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Faron Pharmaceuticals Oy (LSE: FARN)

 
FARN Technical Analysis
2
As on 2nd May 2025 FARN SHARE Price closed @ 200.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 196.57 & Strong Sell for SHORT-TERM with Stoploss of 291.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

FARNSHARE Price

Open 192.50 Change Price %
High 202.90 1 Day 7.50 3.90
Low 186.00 1 Week -10.00 -4.76
Close 200.00 1 Month 12.50 6.67
Volume 15785 1 Year -65.00 -24.53
52 Week High 350.00 | 52 Week Low 92.50
 
LSE UK Most Active Stocks
PREM 0.04 0.00%
MSMN 0.05 0.00%
ENET 0.02 -33.33%
GFIN 0.07 0.00%
UKOG 0.01 0.00%
MIRI 0.03 -25.00%
KEFI 0.64 18.52%
DEMG 0.02 -50.00%
UOG 0.16 0.00%
SMDS 582.50 0.00%
 
LSE UK Top Gainers Stocks
CPI 194.10 1423.55%
CPI 194.10 1423.55%
CPI 194.10 1423.55%
CPI 194.10 1423.55%
CPI 194.10 1423.55%
0YY7 20.40 280.60%
SSIF 18.50 208.33%
CGW 55.03 107.66%
GILD 0.08 100.00%
GILD 0.08 100.00%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
0QQO 94.50 -89.33%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
 
 
FARN
Daily Charts		 FARN
Intraday Charts		 Whats New @
Bazaartrend		 FARN
Free Analysis
 
FARN Important Levels Intraday
RESISTANCE232.57
RESISTANCE222.12
RESISTANCE215.67
RESISTANCE209.21
SUPPORT190.79
SUPPORT184.33
SUPPORT177.88
SUPPORT167.43
 
FARN Forecast May 2025
Share
4th UP Forecast435.09
3rd UP Forecast359.7
2nd UP Forecast313.09
1st UP Forecast266.49
1st DOWN Forecast133.51
2nd DOWN Forecast86.91
3rd DOWN Forecast40.3
4th DOWN Forecast-35.09
 
FARN Weekly Forecast
4th UP Forecast250.10
3rd UP Forecast234.03
2nd UP Forecast224.10
1st UP Forecast214.17
1st DOWN Forecast185.83
2nd DOWN Forecast175.90
3rd DOWN Forecast165.97
4th DOWN Forecast149.90
 
FARN Forecast2025
4th UP Forecast749.2
3rd UP Forecast573.07
2nd UP Forecast464.2
1st UP Forecast355.33
1st DOWN Forecast44.68
2nd DOWN Forecast-64.2
3rd DOWN Forecast-173.07
4th DOWN Forecast-349.2
 
 
FARN Other Details
Segment EQ
Market Capital 180988800.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
FARN Address
FARN
 
FARN Latest News
 
Your Comments and Response on Faron Pharmaceuticals Oy
 
FARN Business Profile
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, cardiovascular surgery, CAR-T induced CRS, acute kidney injury, and IRI in solid organ transplantation; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. The company also develops Haematokine, a new chemical entity AOC3 inhibitor for the treatment of hematological malignancies and bone marrow. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland. Address: Joukahaisenkatu 6 B, Turku, Finland, 20520
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service